Skip to content

Intervention for Postpartum Infections Following Caesarean Section

Intervention for Postpartum Infections Following Caesarean Section - a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01891006
Acronym
APIPICS
Enrollment
26
Registered
2013-07-02
Start date
2011-05-31
Completion date
2015-07-31
Last updated
2016-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound Infection, Infection; Cesarean Section, Cesarean Section; Dehiscence, Complications; Cesarean Section, Complications; Cesarean Section, Wound, Dehiscence, Wound; Rupture, Surgery, Cesarean Section

Keywords

Randomized Controlled Trial, Economical Evaluation, Caesarean Section, Cesarean Section, Postoperative Wound Treatment, Surgical Site Infections, Wound Infections, Infectious Morbidity, Negative Pressure Wound Therapy

Brief summary

The purpose of this study is to examine whether Negative Pressure Wound Therapy is an effective wound treatment compared to conventional wound treatment in the period of time from reoperation to re-suturing in women having surgical wound rupture after Caesarean Section.

Detailed description

This study is a non-blinded randomized controlled trial and a concurrent Health Economic. The study examines the effect on wound healing using NPWT compared with conventional wound treatment in women, who experience spontaneous dehiscence or where a surgeon deliberately opens the wound after Caesarean Section (CS). Women, who have given informed consent, will be randomized to either intervention or control group via a computer-generated randomization program. It is not possible to blind either participants or therapists. The analysis will be carried out on an intention to treat basis. Women with post-CS wound infection will be hospitalized and the wound will be reopened and cleaned under general anaesthesia. In the intervention group women will be treated with NPWT. The change of wound dressing on the second day takes place in the obstetrical or plastic surgery ward. On the fourth day, the NPWT material will be removed and the wound evaluated before re-suturing. In the control group the wound will be treated with a hydrofiber or alginate dressing. Changes of wound dressing will take place on the second and fourth days as in the intervention group. In both groups, when the wound is evaluated on the second and fourth day, it will be described and measured (depth, width, length). After four days of treatment, the wound will be re-sutured in both groups. It is expected that some wounds are not suitable for re-suturing on the fourth day. If a woman does not want to participate, she will receive the conventional treatment, which corresponds to the treatment in the control group. Women, who do not wish to participate, will be asked for permission to use their data in the analysis.

Interventions

DEVICENegative Pressure Wound Therapy

The Negative Pressure Wound Therapy are changed on the 2. day and removed on the 4. day after the re-operation.

The standard wound dressing is a a hydrofiber or alginate dressing used for open wounds

Sponsors

Region of Southern Denmark
CollaboratorOTHER
University of Southern Denmark
CollaboratorOTHER
Hvidovre University Hospital
CollaboratorOTHER
Smith & Nephew, Inc.
CollaboratorINDUSTRY
Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 year * Women, who can read and understand Danish

Exclusion criteria

* Serious illness requiring medical treatment, such as cancer * Stillborn child * If the fascia is ruptured

Design outcomes

Primary

MeasureTime frame
The frequency of re-rupture in each study groupWithin the first 30 days after surgery

Secondary

MeasureTime frameDescription
Length of hospitalizationWithin the first 30 days after Caesarean Section
Readmission to hospital due to wound complications after the re-operationWithin the first 30 days after Caesarean Section
Number of participants with a decreased health-related quality of life score as a measure of satisfaction and tolerabilityWithin the first 30 days after Caesarean SectionA health-related quality of life measure, recorded in Quality Adjusted Life Years at the two interventions. The health-related quality of life score is measured on the 4 day after the re-operation and at the 6 and 12 months follow-up.
The cosmetic outcome as a measure of satisfactionA 6 and 12 months follow-upThe scar will be evaluated by a plastic surgeon at a clinical examination 6 and 12 months after the re-operation. After study completion pictures of the scars will be evaluated by two blinded plastic surgeons, using two predefined scar scales.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026